t.vriesendorp@isala.nl
26 november 2020 bij 18:06- Antwoorden
Thank you for a great talk, and for sharing these interesting data!
It is interesting to think about how we can cost-effectively diagnose unrecognized MODY. Do you know how many patients are tested in your laboratory bc diabetes that was discovered around pregnancy?
Do you think it would be feasible to start with screening lean women (BMI < 25 kg/m2) diagnosed with gestational diabetes (increased fasting glucose for GCK MODY?) and a positive family history of diabetes?
K. van der Tuin (Leiden)
26 november 2020 bij 18:42- Antwoorden
Hi Titia, thanks for your interesting questions. Cost-effectively is an import topic for further investigation. Clinical information is unfortunately often missing on DNA request forms so I don’t have data on pregnancy, however this would be an interesting group to study.
2 Reacties
Thank you for a great talk, and for sharing these interesting data!
It is interesting to think about how we can cost-effectively diagnose unrecognized MODY. Do you know how many patients are tested in your laboratory bc diabetes that was discovered around pregnancy?
Do you think it would be feasible to start with screening lean women (BMI < 25 kg/m2) diagnosed with gestational diabetes (increased fasting glucose for GCK MODY?) and a positive family history of diabetes?
Hi Titia, thanks for your interesting questions. Cost-effectively is an import topic for further investigation. Clinical information is unfortunately often missing on DNA request forms so I don’t have data on pregnancy, however this would be an interesting group to study.